Skip to main content

Table 3 Comparison of regional Burkitt's lymphoma.

From: Epstein-Barr virus and Burkitt’s lymphoma. Associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of Childhood Cancer

Country

ASIR 0-19 year-old

Ratio Child:adult

HDI

sEBV

tEBV

Sulaimani

6.2 (4.7–7.7)

1 : 0.19

0.674

0.92 C

0.83

Egypt

5.2 (4.2–6.2)

1 : 0.05

0.707

Na

0.73

Algeria

1.0 (0.6–1.4)

Na

0.748

0.83 C

0.88

Morocco

5.0 (3.7–6.3)

Na

0.686

Na

Na

Jordan

3.7 (3.1–4.3)

1 : 0.13

0.729

0.98 C

Na

Israel all races

5.0 (4.3–5.7)

Na

0.919

0.87 AYD

0.34

Saudi Arabia

2.8 (2.3–3.3)

Na

0.854

0.98 C

Na

Turkey

3.5 (3.0–4.0)

Na

0.820

0.82 C

0.93

S. Africa all races

1.7 (1.5–1.9)

1 : 2.78

0.709

0.95 EBV

0.78 HIV+

Na

Uganda

21.6 (19.4–23.8)

1 : 0.21

0.544

0.96 EC

>0.95

Cameroon

40.0 (32.9–47.1)

1 : 0.41

0.563

0.97 EC

>0.95

Canada

2.5 (2.3–2.7)

1 : 2.78

0.929

0.95 AYD

Na

US all races

2.4 (2.3–2.5)

1 : 3.85

0.926

0.83 AYD

0.30

UK

2.3 (2.1–2.5)

1 : 4.78

0.932

0.85 AYD

0.10

Germany-West

2.8 (2.4–3.2)

Na

0.947

0.95 AYD

Na

France

4.3 (3.7–4.9)

Na

0.901

0.82 AYD

Na

Italy

4.0 (3.5–4.5)

1 : 0.20

0.892

0.65 AYD

0.62

Spain

4.8 (4.2–5.5)

Na

0.904

0.99 AYD

Na

Japan

1.4 (1.1–1.7)

1 : 2.94

0.919

0.59 AYD

0.29

Korea

2.1 (1.9–2.3)

Ped<Adult

0.916

0.87 AYD

0.00

China

0.4 (0.3–0.5)

1 : 0.55

0.761

0.80 EC

0.32

Thailand

0.8 (0.6–1.0)

Ped>Adult

0.777

0.95 EC

Na

India

0.5 (0.4–0.6)

Ped>Adult

0.645

0.90 EC

Na

  1. Age-specific incidence rates per million 0-19 year old residents are compared together with the ratio of children to adults, Epstein-Barr virus serology, and frequency of tissue EBV latency
  2. Na information not available; ASIR age-specific incidence rate with 95% confidence interval (95% CI); HDI human development index [from the WHO website]; HIV human immunodeficiency virus; Ped, pediatric; EBV Epstein-Barr virus; sEBV population serological EBV frequency; C childhood infection, not further specified; EC early childhood infection, by 5 years of age; AYD adolescent and young adult infection; tEBV lymphoma tissue EBER frequency